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Abstract
Vitamin D may be essential for restricting the development and severity of allergic diseases and asthma, but a direct causal
link between vitamin D deficiency and asthma has yet to be established. We have developed a ‘low dose’ model of allergic
airway disease induced by intraperitoneal injection with ovalbumin (1 mg) and aluminium hydroxide (0.2 mg) in which
characteristics of atopic asthma are recapitulated, including airway hyperresponsiveness, antigen-specific immunoglobulin
type-E and lung inflammation. We assessed the effects of vitamin D deficiency throughout life (from conception until
adulthood) on the severity of ovalbumin-induced allergic airway disease in vitamin D-replete and -deficient BALB/c mice
using this model. Vitamin D had protective effects such that deficiency significantly enhanced eosinophil and neutrophil
numbers in the bronchoalveolar lavage fluid of male but not female mice. Vitamin D also suppressed the proliferation and T
helper cell type-2 cytokine-secreting capacity of airway-draining lymph node cells from both male and female mice.
Supplementation of initially vitamin D-deficient mice with vitamin D for four weeks returned serum 25-hydroxyvitamin D to
levels observed in initially vitamin D-replete mice, and also suppressed eosinophil and neutrophil numbers in the
bronchoalveolar lavage fluid of male mice. Using generic 16 S rRNA primers, increased bacterial levels were detected in the
lungs of initially vitamin D-deficient male mice, which were also reduced by vitamin D supplementation. These results
indicate that vitamin D controls granulocyte levels in the bronchoalveolar lavage fluid in an allergen-sensitive manner, and
may contribute towards the severity of asthma in a gender-specific fashion through regulation of respiratory bacteria.
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Introduction
Vitamin D supplementation is currently under evaluation for
the treatment of many pathological conditions including allergic
and autoimmune diseases characterised by aberrant immunity.
For example, there are currently greater than forty clinical trials
registered at ClinicalTrials.gov in which the potential for vitamin
D supplementation in controlling asthma is being assessed (using
vitamin D and asthma as keywords). Skin exposure to the
ultraviolet rays of sunlight is the main means by which individuals
acquire vitamin D. After exposure to ultraviolet radiation,
epidermal 7-dehydrocholesterol undergoes chemical conversion
to pre-vitamin D, which is then further isomerised to vitamin D, is
bound by the vitamin D-binding protein and relocated to the liver
and kidney for sequential hydroxylations to form 25-hydroxyvi-
tamin D (25(OH)D) and 1,25-dihydroxyvitamin D (1,25(OH)2D).
Immune cells like dendritic cells and macrophages also synthesize
1,25(OH)2D through the expression of hydroxylating enzymes like
the 1a-hydroxylase (CYP7B1) [1]. Vitamin D is also increasingly
acquired through dietary sources particularly in the form of
supplements. The best current measure for determining vitamin D
sufficiency is 25(OH)D, where deficiency is recognised by many to
occur when serum 25(OH)D levels fall below 50 nmol/L [1].
It is currently not clear whether asthmatics have an increased
propensity towards vitamin D deficiency than non-asthmatics.
Circulating 25(OH)D levels were significantly reduced in children
with moderate (mean 25(OH)D = 42 nmol/L) or severe therapy-
resistant (mean 25(OH)D = 28 nmol/L) asthma than non-asth-
matic children (mean 25(OH)D = 56 nmol/L) [2]. In contrast,
other studies have shown that vitamin D deficiency (,50 nmol/L)
is more common in non-asthmatics (57%) than asthmatics (48%)
[3]. In a case-controlled study of age- and sex-matched adults with
and without asthma, there was no significant association between
serum 25(OH)D levels and asthma severity [4]. The role of
vitamin D in controlling the development of asthma is also
controversial. Dietary intake of vitamin D by pregnant mothers
has been associated with reduced asthma/wheezing outcomes in
their children [5,6,7,8]. In contrast, vitamin D intake in the first
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few years of life through oral supplementation has been positively
associated with asthma in most studies [9,10,11]. These observa-
tions have led to the somewhat conflicting hypotheses that vitamin
D deficiency [12] and oral vitamin D supplementation [13] may
both contribute toward the asthma ‘epidemic’. Further recent
hypotheses have drawn links between the potential for vitamin D
to regulate the gut microbiome and the emergence of asthma and
autoimmune disease [14].
There are now a number of studies showing a positive
relationship between serum 25(OH)D levels and lung function in
both adults [15,16] and children [2,17,18,19,20], but again, these
relationships are not exhibited by all populations studied [4,21].
Our own studies have shown that vitamin D deficiency in utero
affects lung development, where 2 week-old BALB/c mice from
vitamin D-deficient mothers had impaired lung volume and
function [22]. Current vitamin D status may also moderate
asthma, especially in children, although again not all studies are in
agreement [18]. Negative correlations of serum 25(OH)D and
asthmatic-related parameters like allergen-specific immunoglobu-
lin type-E (IgE), corticosteroid use and airway hyperresponsiveness
(AHR) have been observed in pediatric populations from Australia
[23], Costa Rica [24], Northern America [3,17,20], Qatar [25]
and the United Kingdom [2].
While in most studies inverse associations between vitamin D
status and asthma-related outcomes have been observed, a direct
causal link between vitamin D deficiency and asthma has yet to be
established. Treatment with the active vitamin D metabolite,
1,25(OH)2D, significantly reduced lung eosinophilia, the severity
of the histopathological changes and AHR in mice with allergic
airway disease [26,27,28,29]. However, vitamin D deficiency had
minimal effects on allergic airway disease induced in C57Bl/6
mice, although these animals became hypocalcemic [30]. In the T
helper cell type-2 (Th2) response prone BALB/c mouse, vitamin D
deficiency reduced the expression of the vitamin D receptor
(VDR) in the lungs of mice with allergic airway disease [31].
Finally, in our own studies, vitamin D deficiency increased the
capacity of airway-draining lymph node (ADLN) cells from
BALB/c mice with ovalbumin (OVA)-induced allergic airway
disease to proliferate and secrete Th2 cytokines in response to ex
vivo OVA stimulation [32]. However, lung eosinophilia and OVA-
specific IgE levels were not modified by vitamin D deficiency.
There is considerable debate about the supra-physiological
doses of allergen and adjuvant used in murine models of asthma
[33,34]. We have previously shown that only 1 mg OVA and
0.2 mg of the Th2-skewing adjuvant Aluminium hydroxide (Alum)
are necessary to sensitize mice, and with these more realistic and
less aggressive levels of sensitization, regulatory effects of genuine
immunomodulators were observed [34]. We hypothesised that the
dose of allergen used to sensitize mice by previous investigators
(including ourselves, [30,32]) may have masked some of the
potential effects of vitamin D deficiency on the severity of allergic
airway disease observed in mice. To assess this hypothesis we
sensitized mice with 1 mg OVA and 0.2 mg Alum and examined
the effects of a ‘lifetime’ of vitamin D deficiency and its reversibility
by vitamin D supplementation in adulthood. With the recent
hypotheses that vitamin D may modulate microflora to regulate
asthma [14], we also examined the effects of vitamin D on
commensal bacterial levels in the lungs of mice with allergic airway
disease.
Materials and Methods
Mice and diet
All experiments were performed according to the ethical
guidelines of the National Health and Medical Research Council
of Australia and with approval from the Telethon Institute for
Child Health Research Animal Ethics Committee. Mice were
purchased from the Animal Resources Centre, Western Australia.
Female 3 wk-old BALB/c mice were placed on semi-pure diets,
which were supplemented with vitamin D3 (2280 IU vitamin D3/
kg, SF05-34, Specialty Feeds, Perth, Western Australia) or were
not supplemented vitamin D3 (0 IU vitamin D3/kg, SF05-033,
Specialty Feeds). The non-vitamin D-supplemented diet was also
supplemented with 2% calcium (vs 1% for the vitamin D-
supplemented diet). At 8 weeks of age, female mice were mated
with adult male BALB/c mice maintained on standard mouse
chow (Specialty Feeds, containing 2000 IU vitamin D3/kg). The
dietary doses of vitamin D in the vitamin D-replete diet are similar
to those found in standard mouse chow (Specialty Feeds).
Offspring born following these matings were maintained on the
vitamin D-replete or -deficient diets for the rest of the experiment,
except in some experiments where initially vitamin D-deficient
mice were switched to the vitamin D-replete diet from 8 weeks of
age, or initially vitamin D-replete mice were switched to the
vitamin D-deficient diet from 4 weeks of age. Mice were housed
under perspex-filtered fluorescent lighting, which emitted no
detectable ultraviolet (UV) B radiation as measured using a UV
radiometer (UVX Digital Radiometer, Ultraviolet Products Inc.,
Upland, CA, USA). Mice transgenic for the OVA323–339
(ISQAVHAAHAEINEAGR)-specific TCR-ab (DO11.10) on a
BALB/c background were originally purchased from the Jackson
Laboratory and bred in-house. DO11.10 mice were used between
the ages of 8–12 wks. Expression of OVA323–339-specific TCR-ab
on T cells was confirmed as previously described [35].
Sensitization and challenge of mice with ovalbumin
OVA (Sigma Chemical Company, St Louis, MO, USA) was
mixed with an aluminium hydroxide suspension (Alum, Serva,
Heidelberg, Germany). This OVA/Alum solution was diluted in
0.9% saline to sensitize and boost mice intraperitoneally (200 ml)
with 1 mg OVA and 0.2 mg Alum [34]. Mice were sensitized on
day 0 and then boosted again on day 14. On day 21, mice were
challenged with a 1% OVA-in-saline (1 mg/ml) aerosol delivered
using an ultrasonic nebulizer (UltraNebs, DeVilbiss, Somerset, PA,
USA) for 30 min. In some experiments, mice were challenged with
OVA on three successive days. In other experiments, mice were
sensitized and boosted with 0.02 mg OVA and 4 mg Alum, 1 mg
OVA and 0.2 mg Alum, or 5 mg OVA and 1 mg Alum.
Bronchoalveolar lavage fluid for assessment of
inflammatory cells and cytokines
Twenty-four hours after the last aerosol challenge with OVA,
BALF was collected as described previously, with a total of 1 ml
collected of BALF for each mouse [36]. BALF cells (56105) were
spun onto glass slides using a cytocentrifuge, and differential
counts of inflammatory cells performed by staining cells with the
DIFF-Quik Stain Set 64851 (Lab Aids, Narrabeen, NSW,
Australia) as per the manufacturer’s instructions. At least 300
cells were counted for each sample from at least 3 independent
fields of view (x100). Levels of IL-4, IL-5, IL-6, IL-10, IL-13, IL-
17, IL-33, GM-CSF, IFNc and TNF in BALF were detected using
an enzyme-linked immunosorbant assay (ELISA) as previously
described [36,37] with antibody pairs supplied by BD Biosciences
(Franklin Lakes, NJ, USA) or eBiosciences (San Diego, CA, USA).
Lung Bacteria Suppressed by Vitamin D in Male Mice
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Assessing the responsiveness of airway-draining lymph
nodes cells
Twenty-four hours after OVA challenge, the posterior medias-
tinal, tracheobrachial and parathymic lymph nodes (airway-
draining lymph nodes, ADLN) were removed, pooled within
experimental groups, physically disaggregated and cultured at 105
cells/200 ml/well (12 replicates per treatment) with OVA (10 mg/
ml) as described previously [32,36,37]. Tritiated-[3H]-thymidine
incorporation was used as a measure of cellular proliferation when
added for the final 24 h of a 72 h culture. Culture supernatants
were also obtained at 72 h and tested for the presence of IL-4, IL-
5, IL-6, IL-10, IL-13, IL-17, IL-33, GM-CSF, IFNc and TNF by
ELISA as previously described [32,36,37].
Measurement of serum and BALF levels of 25-
hydroxyvitamin D (25(OH)D)
Serum and BALF 25(OH)D levels were measured using IDS
EIA kits (Immunodiagnostic Systems Ltd, Fountain Hills, AZ) as
described by the manufacturer (limit of detection was 5-
7 nmol.L21). Serum 25(OH)D levels were measured in female
and male breeding animals at 8 weeks of age prior to mating, and
also in offspring at 8 weeks of age and 3 days before the respiratory
challenge with OVA.
Measurement of OVA-specific IgE and IgG1 in serum
At day 20 (24 h before the first OVA challenge) of the OVA-
induced allergic airway disease model, sera were obtained to test
for OVA-specific IgE and IgG1. OVA-specific IgE levels were
measured using an in vivo passive cutaneous anaphylaxis assay
described previously [32,36]. OVA-specific immunoglobulin type-
G1 (IgG1) levels in serum were measured using an ELISA assay as
previously described [34]. OVA-specific IgE and IgG1 titres are
expressed as log2 and log10, respectively.
Histopathological assessment of lung inflammation
Twenty-four h after OVA aerosol challenge, under 10 cm H2O
pressure, 10% buffered-formalin (in phosphate-buffered saline)
was instilled through the trachea into the lungs of euthanased mice
for 2 h. Lungs were removed and fixed for a further 4 days with
10%-buffered formalin. Tissue sections were stained according to
routine procedures (haematoxylin and eosin (H&E), or Periodic
acid Schiff (PAS)). The distribution of peribronchiolar inflamma-
tion and perivascular inflammation was assessed by a veterinary
histopathologist in a blinded fashion with a score out of four for
each assigned, as per the semi-quantitative scoring system in [38],
where; 0 = none, 1 = minimal/marginal, 2 = mild, 3 = moderate,
4 = severe inflammation. The peribronchiolar and perivascular
scores were added to give a histopathological score for lung
inflammation out of eight.
Measurement of airway hyperresponsiveness
A modified low-frequency forced oscillation technique was used
to measure the change in respiratory system input impedance [39].
Briefly, 24 h after the aerosol challenge with OVA or saline only,
mice were anaesthetized with xylazine (2 mg/ml; Troy Labora-
tories, Smithfield, NSW, Australia) and ketamine (40 mg/ml; Troy
Laboratories) delivered i.p. at a dose of 0.01 ml/g. Mice were
tracheostomized and ventilated (flexiVent, Scireq, Montreal, QC,
Canada) at 450 breaths/min with a tidal volume of 8 ml/kg and a
positive end expiratory pressure of 2 cm H2O. Baseline values
were obtained by measuring impedance five times at 1 min
intervals. A 90 sec saline aerosol was delivered with an ultrasonic
nebulizer (Devilbiss UltraNebs) and impedance was measured five
times at 1 min intervals. This was repeated with Klog10
incremental doses of methacholine (0.3–100 mg/ml) and the peak
response for each parameter was recorded for analysis. The
constant-phase model [40] was used to partition impedance into
components representing the conducting airways (airway resis-
tance) and the lung parenchyma (tissue damping and tissue
elastance).
Measurement of circulating immune cells and cytokines
At 24 h after OVA aerosol challenge, 250 ml of blood was
obtained from mice and immediately added to K2EDTA-coated
Microtainer tubes (BD, Franklin Lakes, NJ) to prevent clotting.
The proportions of circulating eosinophils, neutrophils and
basophils within white blood cells was determined using the
ADVIAH 120 Haematology System (Siemens Healthcare Diag-
nostics Inc, Tarrytown, NY. At day 20 (24 h before OVA
challenge) of the OVA-induced allergic airway disease model, sera
were tested for the presence of GM-CSF by ELISA as previously
described [32,36,37] using antibody pairs from eBiosciences.
In vitro antigen-presenting cell assay
Twenty-four h after OVA challenge, ADLN were removed and
digested with collagenase type 4 (1 mg/ml, Worthington Bio-
chemical, Lakewood, NJ) and DNAse (0.1 mg/ml, Sigma) for
30 min at 37uC. CD11c microbeads (Miltenyi Biotech) were used
with the autoMACS separator (Miltenyi Biotech) to positively
select for CD11c+ cells. Flow cytometry was used to determine
that the purity of live isolated CD11c+ cells was routinely .90%.
The expression of activation markers such as CD86 on the
CD11c+ cells was not modified by this positive selection process
(data not shown).
CD4+ cells were isolated from peripheral lymph nodes
(auricular, axillary, brachial, inguinal, mesenteric and para-aotric)
of DO11.10 mice. A CD4+ T cell isolation kit (Miltenyi Biotech,
Cologne, Germany) was used to isolate the CD4+ cells ($ 95%
pure, as determined by flow cytometry). Cells were resuspended in
RPMI with 10% FCS and 2 mM 2-ME and aliquot into round-
bottomed 96-well plates at 105 cells/0.1 ml/well. OVA323–339
peptide (Proteomics International, Perth, Australia) was added at a
final concentration of 1 mg/ml. CD11c+ cells were added to
CD4+ cells from sex-matched mice at varying ratios (from 1:10 to
1:1280) in replicates of six. After incubation for 72 h at 37uC in
5% CO2, methyl-[
3H]-thymidine (Amersham Biosciences;
0.25 mCi; 10 ml/well) was added to cultures prior to the harvest
of cells at 96 h, with [H3]-thymidine incorporation used as the
measure of cellular proliferation.
FACS analysis of immune cells in airway-draining lymph
nodes
Twenty-four h after OVA challenge, ADLN were removed
from mice, pooled within experimental groups and physically
disaggregated. Staining of surface antigens was performed as
previously described [35]. An intracellular staining kit (eBios-
ciences) was used to determine intracellular Foxp3 expression. At
least 10,000 cells of interest were collected using the FACS LSRII
(BD Biosciences) flow cytometer. Data were analysed using FlowJo
software (v9.5.2, TreeStar Inc, Ashland OR, USA).
Detection of mRNAs in CD11c+ cells from the airway
draining lymph nodes
RNA was purified from 105 purified CD11c+ cells, cDNA
transcribed and real-time PCR performed as described previously
[41], using a Dendritic Cell and Antigen-Presenting Cell RT2
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profiler PCR array (PAM406Z, 96-wells) to detect gene expression
of CCL5, CCL11, CCL19, CCL20, CXCL1 and IL-18RA as
described by the manufacturer (Qiagen, Doncaster, VIC,
Australia). Fold-change was determined by using the 22DDCt
method specified by the manufacturer by combining results
obtained for multiple house-keeping genes.
Detection of mRNAs in BALF cells
Messenger RNA was extracted from BALF cells (2.56105),
cDNA synthesized and real-time assays performed as previously
described using Quantitect Primer Assays (Qiagen) for detection of
mRNAs of CYP2R1, CYP27B1, CYP24A1 and the VDR genes
with EEF1a used as the house-keeping control [42]. Fold-change
was determined by using the 22DDCt method.
Determining bacterial loads in lung samples
Twenty-four h after OVA aerosol-challenge the lungs were
removed from mice. The right lobe of each lung was minced using
a sterile scalpel blade. A 2 mm3 sample of the lung was snap-
frozen in liquid nitrogen. DNA was extracted from lung samples
using the DNeasy Blood and Tissue DNA extraction kit as
described by the manufacturer (Qiagen). Universal 16 S rRNA
primers (F primer = 59-TCCTACGGGAGGCAGCAGT-3`; R
primer is 59-GGACTACCAGGGTATCTAATC CTGTT-3`
[43]) were used for the detection of bacteria in DNA samples
using the Power SYBR Green PCR Master Mix as described by
the manufacturer (Applied Biosystems, Calsbad, USA). These
primers have been shown to be broadly specific for the detection of
bacterial DNA from 34 bacterial species encompassing most
bacterial groups [43]. An 18 S rRNA endogenous control
including a FAM MGB probe was used as the internal control
for this assay using conditions described by the manufacturer
(Applied Biosystems). Fold-change was determined by using the
22DDCt method. BALF samples were also tested for culturable
bacteria on routine clinical media, where 10 ml of pooled BALF
samples (for each treatment) were plated directly onto 5% horse
blood, chocolate and MacConkey agar (all media obtained from
PathWest Laboratory Medicine WA Media, Australia) and
incubated at 35 uC in enriched CO2 (6%). Anaerobic culture
was performed on 5% horse blood agar using a jar and
AnaeroPack-AnaeroH (MGC, Japan) gas pack. Six days of
enrichment prior to subculture to horse blood and chocolate agar
was also performed using cooked meat broth inoculated with 10 ml
of pooled BALF samples. Plates were reviewed at 24, 48 and 120 h
incubation for bacteria colonies.
Statistical analyses
Data were compared using an unpaired two-way student’s t test
using the Prism 5 for Mac OS X statistical analysis program. For
analysis of PCR data, fold-change was transformed by log2 and
then a one-sample t test was performed. An up- or down-
regulation of a particular gene transcript was considered to be
significant with a p-value ,0.05.
Results
Dietary vitamin D suppresses some aspects of OVA-
induced allergic airway disease in male mice, but is
limited by allergen dose
The cumulative effects of a lifetime of vitamin D deficiency were
examined, where 8 wk-old offspring born to vitamin D-deficient
female mice and maintained on a vitamin D-null diet had mean
serum 25(OH)D levels that were,20 nmol/L (n$17 mice/group,
Fig. 1A). Levels of 25(OH)D observed in male mice were
significantly less than those observed in the female mice fed the
vitamin D-containing diet, as shown previously (n$17 mice/
group, Fig. 1A, [32,42]). OVA/Alum sensitisation and boost did
not modify serum 25(OH)D levels (data not shown). Levels of
25(OH)D observed in male mice fed the standard mouse chow
were similar to those reported for male offspring in Fig. 1A. As
shown previously [42], male and female mice fed the vitamin D-
null diet had reduced circulating 1,25(OH)2D levels relative to the
mice fed the vitamin D-containing diet, although there was no
difference between male and female mice per se [42]. There was
no difference in serum calcium levels of mice fed either diet
[32,42].
Vitamin D-replete and -deficient offspring were sensitized and
boosted with 1 mg OVA, 0.2 mg Alum. In three experiments
(n = 15 mice/treatment), vitamin D deficiency significantly
increased the number and percentage of eosinophils and
neutrophils in the BALF of male but not female mice (Fig. 1B,
data not shown for percentages), 24 h after respiratory challenge
with OVA. Indeed, there was no difference in the number and
percentage of eosinophils and neutrophils in the BALF of male
and female vitamin D-deficient mice. There was no significant
increase in BALF cytokine levels with vitamin D deficiency,
including IL-4, IL-5, IL-6, IL-10, IL-13, IL-17, TNF and IFNc
(Fig. 1C and data not shown). We are uncertain as to why a
significant reduction in IFNc was observed in the BALF of female
vitamin D-deficient mice, relative to their -replete counterparts
(Fig. 1C). As observed previously with higher doses of OVA/Alum
[32], vitamin D deficiency enhanced the capacity of ADLN cells to
proliferate and secrete cytokines like IL-4, IL-5, IL-10 (Fig. 1D,
data not shown), but not IL-6, IL-17, TNF or IFNc (data not
shown). As observed previously [44], lung inflammation was more
severe in female than male mice, where BALF eosinophil and
neutrophil numbers (Fig. 1B) and IL-5 levels (Fig. 1C) were greater
in the female relative to the male vitamin D-replete mice.
While BALF granulocytes and the responsiveness of ADLN cells
were enhanced by vitamin D deficiency (Fig. 1), other important
parameters of OVA-induced allergic airway disease were not
modified, including serum levels of OVA-specific IgE (Fig. 2A) and
IgG1 (Fig. 2B). Histopathological assessment of H&E- and PAS-
stained lung sections also revealed no differences between vitamin
D-replete and -deficient mice (Fig. 2C). Goblet cell metaplasia was
not observed in this model of allergic airway disease (Fig. 2D).
Baseline airway responses (airway resistance, tissue elastance or
tissue damping) in male mice were not affected by vitamin D
deficiency (Fig. 2E). In male mice the airway response (airway
resistance) to inhaled methacholine was significantly greater in the
OVA-challenge and OVA-sensitized mice than the response
observed in saline-challenged but OVA-sensitized mice for the
10–100 mg/ml methacholine challenge doses (Fig. 2F). However,
vitamin D deficiency did not significantly modify airway resistance
(Fig. 2F), tissue elastance or tissue damping (data not shown) in
male mice. In controls from our previous experiments we observed
no difference in airway resistance, tissue elastance or tissue
damping between (i) naı¨ve mice, (ii) mice sensitised and boosted
with OVA/Alum and challenged with saline, and (iii) non-
sensitised but OVA-challenged mice [39]. We did not further
examine AHR in female mice because we did not initially observe
an effect of vitamin D-deficiency on granulocyte numbers in the
BALF of female mice. It is clear from the results presented in
Fig. 1B and Fig. 2F that the increased BALF granulocyte numbers
observed in male vitamin D-deficient mice did not correlate with
lung function. In addition, in two experiments (n = 10 mice/
treatment) the effect of vitamin D deficiency on BALF granulocyte
Lung Bacteria Suppressed by Vitamin D in Male Mice
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Figure 1. Vitamin D deficiency enhances granulocyte infiltration into the lungs of male but not female mice. In (A), serum 25-
hydroxyvitamin D (25(OH)D) levels of female BALB/c mice (mothers) fed vitamin D-containing (+) or vitamin D-null (2) diets from 3 weeks of age and
were used to produce offspring at 8 weeks of age. Serum 25(OH)D levels for 8 wk-old male and female offspring are also shown. For serum 25(OH)D
measurements, data is from$17 mice per group. At 8 weeks of age, male and female offspring were sensitized intraperitoneally with 1 mg ovalbumin
(OVA) (0.2 mg Aluminium hydroxide (Alum)). Mice were boosted with the same OVA/Alum dose two weeks after the initial sensitization, and one
week later their airways challenged with aerosolised OVA (1% in saline), with responses assessed 24 h later. In three repeated experiments (n = 15
mice/treatment); (B) the total number of cells as well as the number of eosinophils and neutrophils in bronchoalveolar lavage fluid (BALF) were
enumerated; and (C) BALF levels of interleukin (IL)-5, interferon (IFN)c and IL-10 levels were also determined. In (D), airway-draining lymph node
Lung Bacteria Suppressed by Vitamin D in Male Mice
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numbers in male mice was overcome by sequential challenges with
OVA (3 daily doses), which enhanced eosinophil numbers in
BALF (.100-fold, Fig. 1B; Fig. 3), but had little effect on BALF
IL-5 levels (Fig. 1C; Fig. 3). No differences were also observed
upon histopathological analysis of H&E-stained lung sections from
these mice (data not shown). Multiple OVA challenges also
prevented the capacity for dietary vitamin D to suppress the
proliferation and Th2-cytokine secreting capacity of ADLN cells ex
vivo (data not shown). These results indicate that the effects of
dietary vitamin D for suppression of OVA-induced allergic
airways disease are limited by the dose of allergen used to both
sensitize [32] and also challenge mice (Fig. 3).
Further characterisation of the ‘low dose’ OVA-induced
model of allergic airway disease
To further characterise the ‘low dose’ model of allergic airway
disease, we compared responses 24 h after the OVA challenge in
mice sensitised and boosted with 0.02 mg OVA and 4 mg Alum,
1 mg OVA and 0.2 mg Alum, or 5 mg OVA and 1 mg Alum. In
three experiments (n = 15 mice/treatment), the number of
eosinophils (Fig. 4A) and neutrophils (Fig. 4B) was greatest in
the BALF of mice sensitised with the highest dose of OVA/Alum
(5 mg OVA/1 mg Alum), although neutrophil numbers in the
BALF of female mice were comparable at the 1 mg OVA/0.2 mg
Alum and 5 mg OVA/1 mg Alum doses (Fig. 4B). The high
numbers of neutrophils observed are consistent with our previous
studies [32,36,37]. IL-5 levels in BALF also increased with
increasing dose in the male mice, but were greatest in female
mice at the 1 mg OVA/0.2 mg Alum sensitizing dose (Fig. 4C). In
contrast, IFNc levels in the BALF decreased with increasing
OVA/Alum dose (Fig. 4D). There was no affect of sensitizing dose
on BALF IL-4 or IL-10 levels (data not shown). ADLN cells
exhibited an increased capacity to proliferate (Fig. 4E) and
produce IL-4 (Fig. 4F) and IL-5 (Fig. 4G) and IL-10 (data not
shown) with increasing sensitizing doses of OVA/Alum. For most
measures, responses from female mice were greater than that
observed in male mice, and this was particularly apparent in the
BALF with the 1 mg OVA/0.2 mg Alum dose (Fig. 4A-C). OVA-
specific IgG1 levels in serum (measured 3 days before OVA
challenge) were maximal with 1 mg OVA/0.2 mg Alum.
Vitamin D supplementation reverses the effects of a
‘lifetime’ of vitamin D deficiency on BALF granulocyte
and ADLN cell responses in male mice
In these studies vitamin D deficiency was established in mice
from the point of conception. To determine whether the effects of
vitamin D deficiency observed in male mice were reversible, 8
week-old vitamin D-deficient mice were fed a vitamin D-
containing diet for 4 weeks prior to sensitization. In these mice,
serum levels of 25(OH)D increased to that observed in originally
vitamin D-replete mice, while mice continued on the vitamin D-
null diet exhibited very low levels of serum 25(OH)D (Fig. 5A). In
three experiments (n = 15 mice/treatment), increased eosinophil
(Fig. 5B) and neutrophil (data not shown) levels in the BALF of
originally vitamin D-deficient mice were suppressed by vitamin D
supplementation. IL-5 (Fig. 5B) and IL-13 (data not shown) levels
in BALF were not altered by vitamin D supplementation. Again,
lung inflammation was more severe in female than male mice,
where BALF eosinophil numbers and IL-5 (but not IL-13, data not
shown) levels were greater in the female relative to the male
vitamin D-replete mice (Fig. 5B, also Fig. 1C). In these
experiments, BALF levels of IL-33 and GM-CSF were also
examined, with no affect of vitamin D, but responses were greater
in the female than the male mice (Fig. 5B). The capacity of ADLN
cells to proliferate and secrete cytokines (e.g. IL-5, IL-13) was
significantly suppressed by vitamin D supplementation in both
male and female mice (Fig. 5C, data not shown for IL-13).
Supernatant levels of IL-33 were not affected by vitamin D, but
were low (,10 mg/ml; level of detection ,2 pg/ml). Together,
these results indicate that effects of a ‘lifetime’ of vitamin D
deficiency, including any epigenetic effects induced in utero in male
mice are reversible.
Vitamin D supplementation reduces circulating
neutrophil and basophil numbers in male mice with
OVA-induced allergic airway disease
To evaluate whether vitamin D supplementation modulated the
migration of granulocytes into the lungs from the blood,
circulating levels of eosinophils, neutrophils and basophils were
examined 24 h after OVA challenge. While eosinophil numbers
were not affected, vitamin D supplementation significantly
suppressed the proportions of neutrophils within the white blood
cell population in male but not female mice (Fig. 6). In addition,
the proportion of circulating basophils was significantly lower in
vitamin D-replete mice and was suppressed by vitamin D
supplementation of initially vitamin D-deficient male mice
(Fig. 6). Circulating levels of GM-CSF were not modulated by
vitamin D, when measured 3 days prior to OVA challenge (data
not shown), and as reported in Fig. 5B, dietary vitamin D did not
affect BALF levels of GM-CSF 24 h post-OVA challenge (data not
shown). These results suggest a role for vitamin D in affecting the
mobilisation of granulocytes from the bone marrow into the blood
with the potential to migrate into inflammatory sites like the lungs
of mice with allergic airway disease.
Vitamin D deficiency induced post-weaning increases
BALF granulocyte and ADLN cell responses in male mice
To further confirm that the observed effects of vitamin D were
not due to epigenetic effects induced in utero or neonatally, vitamin
D-replete offspring were fed a vitamin D-deficient diet from 4
weeks of age. Serum 25(OH)D levels were measured four weeks
after the dietary intervention, and were significantly reduced to
levels (Fig. 7A) previously observed in mice fed the vitamin D-
deficient diet throughout life (Fig. 1A, Fig. 5A). Serum 25(OH)D
levels remained unchanged for mice fed the vitamin D-replete diet
(Fig. 7A). At this time, mice were sensitized and boosted with 1 mg
OVA, 0.2 mg Alum. In two experiments (n = 10 mice/treatment),
vitamin D deficiency significantly increased the percentage (but
not numbers) of eosinophils (Fig. 7B) and neutrophils (data not
shown) in the BALF of male but not female mice, 24 h after
respiratory challenge with OVA. As before, there was no
significant increase in BALF cytokine levels with vitamin D
deficiency (e.g. IL-5, Fig. 7C and data not shown for IL-13).
Again, vitamin D deficiency enhanced the capacity of ADLN cells
(ADLN) cells were pooled within treatments (n = 5 mice per treatment) and their proliferation in response to exogenous OVA protein was measured
by the addition of tritiated [H3]-thymidine for the final 24 h of a 72 h culture. Concentrations of IL-4 and IL-5 were measured in the supernatants
(n = 4 wells/treatment) of the cultured ADLN cells. In (D), data is shown for a representative experiment of three independent experiments. (mean +
SEM, *p,0.05, LOD= limit of detection).
doi:10.1371/journal.pone.0067823.g001
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Figure 2. Significant OVA-specific IgE and IgG1, lung inflammation and airway hyperresponsiveness are detected in BALB/c mice.
Eight week-old male and female offspring born to vitamin D-replete or -deficient mothers and maintained on the vitamin D-replete or null diets
(respectively) were sensitized intraperitoneally with 1 mg ovalbumin (OVA) (0.2 mg Aluminium hydroxide (Alum)). Mice were boosted with the same
OVA/Alum dose two weeks after the initial sensitization, and one week later their airways challenged with aerosolised OVA (1% in saline). In (A) and
(B), three days prior to airway challenge, OVA-specific IgE and IgG1 levels, respectively, were measured in the serum of mice (n = 6 per group, with
data representative of one experiment of three). In (C) the extent of lung inflammation induced 24 h after the airway challenge, is shown as
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to proliferate (Fig. 7D) and secrete cytokines like IL-5 and IL-13
(data not shown). These studies confirm that current (and not past)
circulating levels of vitamin D control airway granulocyte and
ADLN cell responses in this low-dose model of OVA-induced
allergic airway disease.
Effects of vitamin D deficiency on dendritic cells and
regulatory T cells
Vitamin D induces tolerance through effects on dendritic cells
(DCs) and regulatory T cells [1,45]. In addition to the effects of
vitamin D deficiency on BALF granulocytes in male mice, we also
observed significantly (p,0.05) increased numbers of ADLN cells
in male (vitD+ 7.360.66106; vitD2 1.060.16107 cells/mouse,
mean6SEM) but not female (vitD+ 8.061.76106; vitD2
9.361.86106 cells/mouse, mean6SEM) vitamin D-deficient
mice, 24 h post-OVA challenge (n = 8–9 mice/treatment pooled
from 3 independent experiments). Vitamin D deficiency did not
affect immunogenicity of DC from the ADLN, where CD11c+
cells purified from the ADLN of vitamin D-deficient or -replete
mice had equivalent capacity to induce the proliferation of CD4+
cells from OVA-TCR transgenic mice (DO11.10) (Fig. 8A).
Reduced numbers of MHC classII+ CD11c+CD82 DCs were
observed in the ADLN of female but not male vitamin D-deficient
mice (Fig. 8B). Migratory DCs express low levels of CD8 [46], and
thus it is possible that vitamin D deficiency compromises DC
migration in female mice. In further analysis of cell populations
from the ADLNs, we did not observe any differences in the
number of regulatory T cell (CD4+CD25+Foxp3+) or effector T
cell (CD4+CD25+Foxp32) populations in vitamin D-replete or -
deficient mice (Fig. 8C).
DC production of chemokines may affect the migration of
granulocytes into the respiratory tract [47]. We hypothesised that
chemokine production by airway-associated DCs may have
affected the migration of granulocytes during vitamin D deficiency
in male, but not female mice. We assessed the expression of
mRNAs of a number of chemokines in purified CD11c+ cells,
including CCL5 (Rantes), CCL11 (Eotaxin), CCL19 (MIP-3b),
CXCL1 (KC) and the receptor for IL-8 (IL-8RA). Increased
expression of CCL19 mRNA was observed in the CD11c+ cells
from male vitamin D-deficient mice, when compared to their
vitamin D-replete counterparts, while vitamin D deficiency down-
regulated the expression of mRNAs of CCL11, CCL19, CCL20
and CXCL1 in CD11c+ cells from female mice (Fig. 8D). Thus
vitamin D deficiency differentially affects the expression of CCL19
mRNA by ADLN DC in male and female mice.
Vitamin D deficiency enhances the expression of mRNAs
of vitamin D-related molecules by BALF cells
The expression of mRNAs encoding the vitamin D receptor
(VDR), and enzymes controlling the production of 25(OH)D
(CYP2R1) and 1,25(OH)2D (CYP27B1) and the breakdown of
1,25(OH) 2D (CYP24A1) were examined in BALF cells from
vitamin D-replete, -deficient and -deficient mice supplemented
with vitamin D, 24 h after respiratory challenge with OVA.
CYP27B1 and CYP24A1 gene expression was not detected in
BALF cells, indicating that at this time, these cells are not
producing detectable quantities of the enzymes that make and
break down 1,25(OH)2D. In contrast, VDR (mean CT-val-
ues = 28.9) and CYP2R1 (mean CT-values = 33.0) mRNA levels
were significantly increased in BALF cells from vitamin D-
deficient male mice (relative to female mice), and this increase was
reversed by vitamin D supplementation (Fig. 9).
Vitamin D deficiency enhances the burden of bacteria in
the lungs of male mice with OVA-induced allergic airway
disease
Plausible links between vitamin D, commensal bacteria and
asthma have already been postulated [14]. We hypothesised that
dietary vitamin D may co-regulate both commensal bacterial levels
and inflammation in the lungs of mice with allergic airway disease.
histopathology scores and representative H&E-stained sections exhibiting the average peribronchiolar (score = 1.5; minimal to mild) and perivascular
(score = 2; mild) inflammation (indicated by arrows) which mainly consisted of eosinophils (n = 5 per group, 206magnification; B = bronchioles;
V = veins). In (D), mucus-secreting (goblet) cells were detected (indicated by arrow and pink staining), with a representative PAS-stained lung section
shown. In (E), baseline airway resistance and tissue mechanics (tissue elastance and tissue damping) were measured in non-sensitised male offspring
mice (n$7 mice/treatment). In (F), airway resistance to increasing concentrations of the bronchoconstrictor methacholine was determined in male
offspring mice, 24 h after airway challenge with OVA, or saline only, are shown for OVA-sensitised mice (Baseline = values obtained by measurement
of impedance five times at 1 min intervals after stabilization of the mouse on the ventilator; saline = values obtained by measurement of impedance
five times at 1 min intervals after a 90 sec saline aerosol;% saline =% increase of saline values for increasing doses of methacholine). Airway resistance
is shown as (n$7 mice/treatment) relative to baseline levels (100%). (mean 6 SEM *p,0.05).
doi:10.1371/journal.pone.0067823.g002
Figure 3. Multiple ovalbumin aerosols overcome the capacity
of physiological vitamin D to modulate airway inflammation.
Eight week-old male and female offspring born to vitamin D-replete or -
deficient mothers and maintained on the vitamin D-containing or null
diets (respectively) were sensitized intraperitoneally with 1 mg ovalbu-
min (OVA) (0.2 mg Aluminium hydroxide (Alum)). Mice were boosted
with the same OVA/Alum dose two weeks after the initial sensitization,
and one week later their airways challenged with aerosolised OVA (1%
in saline) on three consecutive days. The total number of bronchoal-
veolar lavage fluid (BALF) cells, and the number of eosinophils and
neutrophils 24 h after the final OVA challenge are shown along with IL-
5 levels. Data is shown as mean+SEM for 10 mice/treatment combined
from two independent experiments.
doi:10.1371/journal.pone.0067823.g003
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Using universal 16 S rRNA primers to measure commensal
bacterial levels, a significantly increased bacterial burden was
detected in the lungs (mean 16 S rRNA CT-values = 29.9) of
vitamin D-deficient male mice (Fig. 10). This increased burden
was significantly reduced by vitamin D supplementation to levels
observed in vitamin D-replete mice. Vitamin D deficiency and
Figure 4. The dose of allergen used to sensitise mice determines the extent of allergic airway disease. At 8 weeks of age, male and
female mice were sensitized intraperitoneally with either 0.02 mg ovalbumin (OVA) (4 mg Aluminium hydroxide (Alum)), 1 mg OVA (200 mg Alum), or
5 mg OVA (1 mg Alum). Mice were boosted with the same OVA/Alum dose two weeks after the initial sensitization, and one week later their airways
challenged with aerosolised OVA (1% in saline), with responses assessed 24 h later. In three repeated experiments (n = 15 mice/treatment) the
number of (A) eosinophils and (B) neutrophils in bronchoalveolar lavage fluid (BALF) were enumerated and BALF levels of (C) interleukin (IL)-5 and
(D) interferon (IFN)c were also determined. In (E), airway-draining lymph node (ADLN) cells were pooled within treatments (n = 5 mice per treatment;
shown are results of a representative experiment) and their proliferation in response to exogenous OVA protein was measured by the addition of
tritiated [H3]-thymidine for the final 24 h of a 72 h culture. Concentrations of (F) IL-4 and (G) IL-5 were measured in the supernatants (n = 4 wells/
treatment) of the cultured ADLN cells. In (H), three days prior to airway challenge, OVA-specific IgG1 levels were measured in the serum of mice.
(mean 6 SEM, *p,0.05).
doi:10.1371/journal.pone.0067823.g004
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Figure 5. Vitamin D supplementation reverses the effects of deficiency on bronchoalveolar lavage fluid granulocytes and lymph
node cell responsiveness. Male and female offspring born to vitamin D-replete or -deficient mothers and maintained on the vitamin D-replete or
null diets (respectively), or vitamin D-deficient offspring switched to a vitamin D-replete diet from 8 weeks of age (VitD- to vitD+, 2/+), were
sensitised at 12 weeks of age intraperitoneally with 1 mg ovalbumin (OVA) (0.2 mg Aluminium hydroxide (Alum)). Mice were boosted with the same
OVA/Alum dose two weeks after the initial sensitisation, and one week later their airways challenged with aerosolised OVA (1% in saline). In (A),
serum 25-hydroxyvitamin D (25(OH)D) levels prior to and 4 weeks after the dietary intervention (n = 4 mice/treatment, mean 6 SEM). In (B), at 24 h
after OVA challenge, the number of eosinophils and IL-5, IL-33 and GM-CSF levels in bronchoalveolar lavage fluid (BALF) with data is shown as mean +
SEM for $15 mice/treatment combined from three independent experiments. In (C), at 24 h after airway challenge with OVA, airway-draining lymph
node (ADLN) cells were pooled within treatments (n = 5 mice/treatment) and their proliferation in response to exogenous OVA protein was measured
by the addition of tritiated [H3]-thymidine for the final 24 h of a 72 h culture. Concentrations of interleukin (IL)-5 were also measured in the
supernatants (n = 4 wells per treatment) of the cultured ADLN cells. For (C), data is shown as mean + SEM for a representative experiment of three
independent experiments.
doi:10.1371/journal.pone.0067823.g005
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subsequent supplementation did not modify bacterial loads in the
lungs of female mice (Fig. 10). Pooled BALF samples (within
treatments) were inoculated onto 5% horse blood, chocolate and
MacConkey agar for growth in enriched CO2 and also anaero-
bically on blood agar to test for the presence of known (or other)
bacterial respiratory pathogens in mice, including Pseudomonas
aeruginosa, Pasteurella pneumotropica, Corynebacterium kutscheri, Staphylo-
coccus aureus, S. epidermidis, Streptococcus spp., Klebsiella spp. and Proteus
mirabilis [48]. However, no bacteria were cultured from these
samples, even with anaerobic incubation and 6 days enrichment in
cooked meat broth prior to subculture to horse blood and
chocolate agar. These results suggest that it is the non-culturable
microbiome that is altered by vitamin D and point to an important
role for commensal bacteria in determining the intensity of lung
inflammation in male vitamin D-deficient mice.
Discussion
Here we provide new evidence for a direct causal link between
vitamin D deficiency and asthma. We used a ‘low dose’ model of
allergen sensitization to determine whether vitamin D deficiency
altered the severity of allergic disease in BALB/c mice. We showed
that deficiency in circulating vitamin D levels increased granulo-
cyte numbers and commensal bacterial levels in the lungs of male
mice with OVA-induced allergic airway disease. Furthermore, the
capacity for ADLN cells to proliferate and secrete Th2 cytokines
was exacerbated by vitamin D deficiency in both male and female
mice. These effects were reversed by vitamin D supplementation,
or induced by post-weaning vitamin D deficiency, suggesting that
recent supplementation and ‘current’ vitamin D status are more
important for their regulation than long-lived epigenetic modifi-
cations established by in utero vitamin D deficiency. These results
highlight the potential contribution that therapies involving
vitamin D supplementation may have for the control of the lung
inflammation that occurs in asthmatics, where vitamin D may
elicit its protective effects through regulation of the respiratory
microbiome.
The lung contains quantities of bacterial communities compa-
rable to the upper respiratory tract, where colonization by certain
bacterial species can promote lung inflammation [49]. For
example, specific bacterial species (eg. Chlamydia pneumoniae) have
been linked with asthma exacerbations (reviewed in [49]) and the
lungs of asthmatic individuals are more likely to colonised by
proteobacteria [50]. From the results of our studies, we propose
that in male mice circulating levels of 25(OH)D may control
bacterial levels and thus the infiltration of granulocytes into the
lungs. The mechanism for this is unclear but may involve sex
differences in the regulation of antimicrobial peptides and
antibacterial defence systems. A link between sex, antimicrobial
peptides and asthma has already been established where single
nucleotide polymorphisms in the ß-defensin-1 gene were associ-
ated with the diagnosis of asthma in female but not male subjects
[51]. In addition, serum 25(OH)D levels in children of the West
Australian Pregnancy Cohort (Raine Study) at both 6- (n = 989)
and 14-years (n = 1380) of age, were negatively associated with
concurrent allergic phenotypes, whereupon sex stratification
revealed that this association was restricted mainly to boys [23].
Our analysis of OVA-induced allergic airway disease in vitamin
D-deficient mice also reflects a similar male bias. In other studies,
rhinovirus infection, now known to be strongly associated with
asthma exacerbations [49], occurred more frequently in male than
female infants hospitalized for respiratory infections [52].
Furthermore, increased oral corticosteroid use was observed in
vitamin D-deficient boys, relative to vitamin D-replete boys of the
Childhood Asthma Management Program [53]. Finally, male
mice are more susceptible to respiratory infection with some (but
not all) bacteria, including Mycobacterium species (reviewed in [54]).
In the current studies, vitamin D deficiency did not result in
enhanced detectable colonisation by ‘culturable’ and known
murine respiratory pathogenic bacteria such as Mycobacterium
species or Pasteurella pneumotropica in the lungs of male mice. In
future studies, we will examine how vitamin D deficiency
differentially affects the non-culturable bacterial microflora of
the lungs of male and female mice through deep-sequencing
methods such as 454 pyro-sequencing.
There is already substantial evidence linking the protective
effects of antimicrobials for dampening the severity of allergic
airways disease in mice. An example is cathelin-related antimi-
crobial peptide (CRAMP), the mouse homologue of human
cathelicidin. Cells that express cathelicidins include neutrophils,
macrophages, mast cells and epithelial cells (reviewed in [55,56]).
The expression of CRAMP is induced in the lungs during infection
with Gram-negative bacteria [57], which rapidly disseminate in
knockout mice that do not express CRAMP [58]. Neutrophil
influx is delayed early during respiratory infection with Gram-
Figure 6. Vitamin D supplementation suppresses circulating neutrophil and basophil levels in male mice. Male and female offspring
born to vitamin D-replete or -deficient mothers and maintained on the vitamin D-replete or null diets (respectively), or vitamin D-deficient offspring
switched to a vitamin D-replete diet from 8 weeks of age (VitD2 to vitD+, 2/+), were sensitised at 12 weeks of age intraperitoneally with 1 mg
ovalbumin (OVA) (0.2 mg Aluminium hydroxide (Alum)). Mice were boosted with the same OVA/Alum dose two weeks after the initial sensitisation,
and one week later their airways challenged with aerosolised OVA (1% in saline). Twenty-four h after the OVA challenge, the proportions of
eosinophils, neutrophils and basophils of circulating white blood cells (WBC) is shown as mean + SEM for n = 5 mice/treatment for a representative
experiment.
doi:10.1371/journal.pone.0067823.g006
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negative bacteria [58]. Somewhat paradoxically, inhaled gluco-
corticoids, often a very effective treatment of asthma, decreased
the expression of CRAMP, increasing the number of internalized
P. aeruginosa and lung histopathology in infected mice with OVA-
induced allergic airway disease [59]. In mice with OVA-induced
allergic airway disease, CRAMP protein is not detectable by
western blotting of cells in BALF but is detected with further
infection with P. aeruginosa [57].
Alternatively, the inability of vitamin D to modulate granulo-
cytes and bacteria in the lungs of the female mice may have been
due to hormonally-regulated control mechanisms. In particular,
there are known interactions between estrogen and vitamin D. A
functional synergy has been proposed between 1,25(OH)2D and
17-b-estradiol, mediated through estrogen receptor-a, to affect
expression of the VDR, vitamin D-inactivating enzyme
(CYP24A1) and vitamin D-binding protein [60,61]. T cells from
female subjects with multiple sclerosis have reduced expression of
CYP24A1 transcripts [61]. In addition, CD4+ T cells and
macrophages from female subjects had an increased ability to
take-up the vitamin D-binding protein [61]. Active vitamin D
(1,25(OH)2D) more potently induces CD4+CD25+Foxp3+ (regu-
latory) T cells from PBMCs of female than male subjects with
multiple sclerosis [61]. In mice with autoimmune encephalomy-
elitis, the expression of the VDR in the spinal cords was
potentiated by estrogen treatment [60]. The cumulative effects
of estrogen on vitamin D metabolism and immune cell function
highlights how females may be more resilient to the effects of
vitamin D deficiency than males.
Along with increased granulocytes in the BALF of vitamin D-
deficient male mice, we also observed significant increases in the
Figure 7. Vitamin D deficiency induced post-weanling enhances granulocyte infiltration into the lungs of male but not female mice.
Male and female offspring born to vitamin D-replete mothers were maintained on the vitamin D-replete diets, or switched to a vitamin D-deficient
diet from 4 weeks of age (VitD+ to vitD2, +/2). Offspring were sensitised at 8 weeks of age intraperitoneally with 1 mg ovalbumin (OVA) (0.2 mg
Aluminium hydroxide (Alum)). Mice were boosted with the same OVA/Alum dose two weeks after the initial sensitisation, and one week later their
airways challenged with aerosolised OVA (1% in saline). In (A), serum 25-hydroxyvitamin D (25(OH)D) levels prior to and 4 weeks after the dietary
intervention (n = 4 mice/treatment, mean6 SEM). In (B), at 24 h after OVA challenge, the number and percentage of eosinophils and in (C) IL-5 levels
in bronchoalveolar lavage fluid (BALF) is shown as mean + SEM for 10 mice/treatment combined from two independent experiments. In (D), at 24 h
after airway challenge with OVA, airway-draining lymph node (ADLN) cells were pooled within treatments (n = 5 mice/treatment) and their
proliferation in response to exogenous OVA protein was measured by the addition of tritiated [H3]-thymidine for the final 24 h of a 72 h culture. For
(D), data is shown as mean + SEM for a representative experiment of two independent experiments.
doi:10.1371/journal.pone.0067823.g007
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expression of mRNAs of the VDR and CYP2R1 genes in BALF
cells (levels of CYP27B1 and CYP24A1 mRNAs were undetect-
able). These results may reflect changes in the populations of
BALF cells by in-coming cells (eg. granulocytes), which may have
enhanced expression of the VDR and CYP2R1 mRNAs relative to
other cells. Alternatively, increased expression of the VDR and
CYP2R1 may result from a homeostatic response of BALF cells to
counter the effects of vitamin D deficiency. We also have
previously reported that the reduced 25(OH)D levels in male
mice may be due to increased turnover of 25(OH)D as male mice
have increased renal expression of mRNAs of the enzyme that
makes 1,25(OH)2D (CYP27B1) [42]. Our current study adds to
the accumulating evidence [42,60,61] that vitamin D metabolism
and effects of vitamin D on immunity and susceptibility for
infection, differs in a sex-dependent fashion.
Viral infection is now commonly thought to induce asthma
attacks (reviewed in Brar et al 2012). Vitamin D may reduce the
rates of asthma exacerbation by enhancing innate immune
mechanisms like antimicrobial peptide production to promote
better control of viral infection in asthmatics (reviewed in [1]).
Visits to hospital emergency departments and/or hospitalization
rates (measures of asthma exacerbation) are associated with
reduced circulating levels of serum 25(OH)D in asthmatic children
[2,17,24,62,63]. In addition, first trimester maternal [64] and cord
blood [65] levels of 25(OH)D were associated with a reduced risk
of respiratory infection in infants at three or twelve months of age,
respectively. Recent clinical trials show that this increased risk may
be ablated by supplementation with vitamin D. In a randomized
trial, when school children were supplemented with 1200 IU/day
vitamin D, both the incidence of influenza A infections and the
number of asthma attacks in children previously diagnosed with
asthma were significantly reduced [66]. These studies indicate that
vitamin D supplementation may be a promising strategy for the
prevention of asthma exacerbations potentially by reducing the
risk for respiratory infection. In future studies, it will be interesting
to determine whether increased lung bacterial loads in male
vitamin D-deficient mice predispose them towards more severe
asthma exacerbations upon viral challenge.
The increased migration of granulocytes into the airways of
vitamin D-deficient male mice may have been mediated through
enhanced expression of chemokines like CCL19 (MIP-3b) by
airway-associated DCs. CCL19 acts through CCR7 [67], which is
expressed by a subset of neutrophils [68], eosinophils [69] and
basophils [70]. The increased eosinophils and neutrophils
observed in the BALF of vitamin D-deficient male mice were
also accompanied by enhanced circulating levels of basophils,
which have very recently been linked with commensal flora levels
in mice [71]. It should be noted that the ADVIA 120 hematology
counter may underestimate the number of basophils in specimens
and does not perform as well as other methods like flow cytometry
for determining circulating basophil numbers [72]. However,
serum 25(OH)D levels have previously been negatively associated
basophils [23] and other circulating granulocytes including
eosinophils [23,24] and neutrophils [23]. Increased circulating
basophils occurred in mice treated orally with antibiotics, which
also exhibited exaggerated basophil-mediated Th2 responses and
Figure 8. Vitamin D deficiency does not affect the immunogenicity of dendritic cells or the numbers of regulatory T cells in the
airway-draining lymph nodes. Eight week-old male and female offspring born to vitamin D-replete or -deficient mothers and maintained on the
vitamin D-containing or -null diets (respectively) were sensitized intraperitoneally with 1 mg ovalbumin (OVA) (0.2 mg Aluminium hydroxide (Alum)).
Mice were boosted with the same OVA/Alum dose two weeks after the initial sensitization, and one week later their airways challenged with
aerosolised OVA (1% in saline). Cells were assessed twenty-four h after OVA challenge. In (A), the capacity of CD11c+ cells isolated from the ADLN to
process and present antigen to co-cultured CD4+ T cells from DO11.10 mice was determined by [3H]-thymidine incorporation for the final 24 h of
96 h co-culture with 1 mg/ml OVA peptide. Results are shown of a representative of 3 independent experiments (mean6SEM) for CD11c+ cells
cultured at various ratios with CD4+ cells. In (B), the FACS gating strategy used to determine the percentage of ClassII+CD11c+CD82 cells in ADLN for
8–9 mice per treatment pooled from 3 independent experiments (mean6SEM). In (C), the FACS gating strategy used to determine the percentage of
CD3+CD4+ T cells and CD3+CD4+CD25+Foxp3+ and CD3+CD4+CD25+Foxp32 cells in the ADLN for 8–9 mice per treatment pooled from 3
independent experiments (mean6SEM). In (D), the expression of CCL5, CCL11, CCL19, CCL20, CXCL1 and IL-18RA mRNAs in CD11c+ cells isolated
from pooled ADLN of ten mice per treatment with results shown from 3 independent experiments (mean+SEM). (*p,0.05).
doi:10.1371/journal.pone.0067823.g008
Figure 9. Vitamin D deficiency increases the expression mRNAs of genes encoding the vitamin D receptor and 25-hydroxylase
enzyme in bronchoalveolar lavage cells of male mice. Male and female offspring born to vitamin D-replete or -deficient mothers and
maintained on the vitamin D-replete or null diets (respectively), or vitamin D-deficient offspring switched to a vitamin D-replete diet from 8 weeks of
age (VitD2 to VitD+), were sensitised at 12 weeks of age intraperitoneally with 1 mg ovalbumin (OVA) (0.2 mg Aluminium hydroxide (Alum)). Mice
were boosted with the same OVA/Alum dose two weeks after the initial sensitisation, and one week later their airways challenged with aerosolised
OVA (1% in saline). Shown are relative levels of mRNA of the vitamin D receptor and 25-hydroxylase (CYP2R1) genes induced by being male in
bronchoalveolar lavage (BALF) cells (n$7 mice per group with data as shown as mean + SEM, *p,0.05 between groups,#p,0.05 relative to levels in
female mice).
doi:10.1371/journal.pone.0067823.g009
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allergic inflammation [71]. In our studies, circulating basophil
numbers also correlated with capacity of ADLN cells to proliferate
and produce IL-5 in both male and female mice with allergic
airway disease. In other studies, a lack of an observed effect of
serum 25(OH)D observed upon sputum granulocyte numbers may
been masked by anti-inflammatory therapies used to treat children
with moderate or severe, therapy-resistant asthma [2].
The observed, potentially beneficial effects of dietary vitamin D
on BALF granulocyte numbers in male mice were overcome by
increasing the burden of allergen used to sensitize mice [32] or the
cumulative quantity used to challenge mice, indicating that
excessive allergen exposure may overpower any advantage
obtained from having sufficient vitamin D. Because of the these
observations, we suggest that the suppressive effects of vitamin D
on granulocyte numbers in the BALF of male mice (challenged
once with OVA) were unlikely to be due to the introduction of
LPS through the aerosol challenge of mice with OVA. We also
examined the effects of vitamin D deficiency upon mice
intranasally sensitized with 10 daily doses of 25 mg house dust
mite (Dermatophagoides pteronyssinus) extract (Greer Laboratories).
Vitamin D deficiency did not exacerbate BALF granulocyte
numbers in either male or female house dust mite-sensitized mice,
when cells were examined 24 h after the final intranasal treatment
(data not shown). We hypothesize, that like the ‘high dose’
sensitization models for OVA-induced allergic airway disease (eg.
20 mg OVA, 4 mg Alum, [32]), the quantities of house dust mite
extract used to sensitize mice need to be further optimised before
any regulatory effect of dietary vitamin D can be observed. We
also suggest that utilising ‘low dose’ allergen sensitization may be
more appropriate to model responses in humans and have
previously used a similar ‘low dose’ model to show that ultraviolet
radiation can modulate OVA-induced allergic airway disease in
pre-sensitized mice [34].
In conclusion, our findings reiterate the importance of
maintaining sufficient vitamin D levels for better lung health,
and also highlight why it is essential to examine potentially
differing pathological responses in both males and females.
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